Patient-specific Prescriptions for Non-food Producing Animals Gain Importance amid COVID-19 Pandemic

The revised draft guidance by the Food & Drug Administration (FDA) is supporting adherence to patient specific prescriptions for non-food producing animals. However, it is relatively challenging for companies in the animal drug compounding market to adapt toward this change amid uncertainties surrounding the COVID-19 pandemic.

In order to keep economies running during the ongoing COVID-19 outbreak, companies in the animal drug compounding market are boosting their output capacities to compound antidotes for food producing animals. Since livestock and pet owners are concerned for the health of their animals, manufacturers are being told to make innovations in FDA approved drugs as a starting point instead of beginning from active pharmaceutical ingredients (API).

animal drug compounding market segmentation

To know the scope of our report Get a Sample on Animal Drug Compounding Market

Lack of Education for Equine Compounding Inhibit Market Growth

The animal drug compounding market is projected to climb a revenue growth from US$ 1 Bn in 2019 and cross US$ 1.7 Bn by 2030. However, it has been found that equine compounding is creating challenges for veterinarians and compounders due to lack of education. Hence, PCCA - a provider of complete resources for compounding pharmacies is helping companies in the animal drug compounding market to develop custom horse medications.

Veterinarians and compounders are becoming cognizant about guidelines issued for horses involved in equestrian sports. Strict rules of the Association of Racing Commissioners International (RCI) and the United States Equestrian Federation (USEF) help improve the quality of life in horses. Manufacturers are innovating in pain relievers, stimulants, and relaxing agents to tap into growth opportunities.

Get a glimpse of the in-depth analysis through our Report Brochure

Ingredient Providers Helping Companies Innovate in Compounding for Exotic Animals

Companies in the animal drug compounding market are increasing efforts to maintain a full line of chemicals and supplies to support veterinary compounding. Letco Medical - a supplier of pharmaceutical ingredients, is gaining recognition for maintaining a formula database, which helps to find the right mixture for any animal. Manufacturers in the animal drug compounding market are working closely with ingredient suppliers who provide APIs, bases, flavors, and formulas that support veterinary compounding.

Manufacturers are focusing on quality assurance and compliance to stringent standards to bolster their credibility in the market landscape. Apart from dogs and cats, companies are increasing their compounding capabilities for horses, birds and other exotic animals that swim and fly.

Innovations in Veterinary-Anesthesia, Pain-Management Medications Boost Market Growth

Inorganic strategies, such as mergers and acquisitions are gaining prominence in the animal drug compounding market. Wedgewood Pharmacy - a PCAB®-accredited compounding pharmacy has announced the acquisition of Wildlife Pharmaceuticals, Inc. and its subsidiary ZooPharm to leverage incremental opportunities with innovations in veterinary-anesthesia and pain-management medications.

Manufacturers in the animal drug compounding market are extending their care for resident wildlife, non-domestic species, companion animals, and captive exotic breeds. They are increasing efforts to develop teams, co-ordinate resources, and expand customer relationships to boost company credentials. Companies are focusing on research and development to advance in specialized medications for managing aquariums, wildlife management organizations, conservation facilities, and private ranches.

Flavored Suspensions, Custom Medications Aid in Easy Administration of Pets

Custom-compounded medications have become a fast-growing phenomenon in the animal drug compounding market. Erie Pharmacy is gaining popularity for its comprehensive product portfolio in custom oral capsules, flavored suspensions, and compounded tablets. Since compounded drugs can be a life-saving option for difficult to medicate pets, owners are seeking consultation from veterinarians for compounding and customizing the strength of medication doses.

Factory made medication in many cases do not suit cats and dogs. Hence, companies in the animal drug compounding market are offering custom services in drug development to alter the medications as per specific doses and formulations that are easier to administer in pets. The combination of several ingredients has led to innovations in easy to swallow oral capsules. Flavored suspensions are serving as palatable options for pets that involve flavor enhancers such as fish, beef, peanut butter, and banana, among others.

animal drug compounding market infographic

Expanding operations in future? To get the perfect launch ask for a custom report 

Analysts’ Viewpoint

Companies in the animal drug compounding market are establishing robust supply chains for customers at wildlife management organizations, private ranches, and conservation facilities, owing to COVID-19 travel restrictions. Companies are boosting their output capacities in compounded tablets and chews with flavored options for pets who are too sick to swallow. Patented combinations of butorphanol tartrate, azaperone tartrate, and medetomidine hydrochloride in medications aid in pain management. However, lack of education in equine compounding and stringent regulations by equestrian sports authorities are causing an impediment in market growth. Hence, companies should increase their production capabilities in compounding custom horse medication to overcome these challenges.

Animal Drug Compounding Market: Overview

  • The global animal drug compounding market was valued at US$ 1.1 Bn in 2019 and is projected to expand at a moderate CAGR from 2020 to 2030. Increase in demand for companion animals, rise in the number of licensed veterinarians or pharmacists, and limited number of FDA-approved drug products for several species and conditions are anticipated to boost the global animal drug compounding market during the forecast period.
  • Intermittent drug shortages and commercial unavailability of FDA-approved drug products drive the need of compounded preparations within veterinary practice. In species such as zoo animals, laboratory animals, exotic pets, wildlife, aquaria, and non-food aquaculture animals, the use of compounded preparations is paramount. Additionally, regulatory bodies are in the process of considering the critical need of access to compounded preparations within these species, which is a key factor driving the market.
  • Drug compounding is a process of mixing, combining, and altering the ingredients for developing tailor-made medications for animals. Compounded animal drugs are manufactured by veterinarians and pharmacists. Drug compounding is also considered when there are no appropriate drugs available for the treatment of a sick animal. Pharmacists consider two ways for compounding an animal drug: extra-label drugs and bulk ingredients. Compounded drugs are economical and most viable options for pet owners without insurance.
  • Veterinarians offer medical care through compounded drugs for various animal species such as zoo animals, exotic animals, and wild animals. Compounded drugs deliver vital medications to a patient; however, these drugs are not approved by the U.S. FDA.

Animal Drug Compounding Market: Segmentation

  • The global animal drug compounding market has been segmented based on product, animal type, dosage form, and route of administration
  • In terms of type, the global animal drug compounding market has been classified into anti-infectives, anti-inflammatory, CNS agents, GI drugs, and others. The CNS agents segment held the largest market share in 2019. The CNS agents segment has been segregated into potassium bromide, gabapentin, and other agents. CNS agents are highly prescribed medications in animals. Potassium bromide was among the most commonly prescribed drug, accounting for 48.7% market share, followed by diazepam, gabapentin, and fluoxetine. This is expected to fuel the growth of the segment during the forecast period.
  • Based on animal type, the global market has been bifurcated into companion animal and livestock. The companion animal segment accounted for the largest market share in 2019, which is ascribed to rise in pet ownership, easy availability of caring facilities, and rapid global urbanizationThe global urban population has increased significantly from 0.75 billion in 1950 to 4.22 billion in 2018. This, in turn, is projected to drive the companion animal segment in the upcoming years.
  • In terms of dosage form, the global animal drug compounding market has been categorized into capsule, solution, powders, suspension, and others. The suspension segment held the largest market share in 2019. Oral suspension is a widely adopted drug administration method for animals. The taste of most drugs is less noticeable in suspension compared to solution, as the drug is less soluble in suspension. For instance, itraconazole is a common drug administered in oral suspension form.
  • Based on route of administration, the global animal drug compounding market has been divided into oral, injectable, topical, rectal, and ocular. The oral segment accounted for the largest market share in 2019, attributed to rise in number of pet ownerships and incidence of diseases in animals.

Animal Drug Compounding Market: Regional Segmentation

  • In terms of region, the global animal drug compounding market has been segmented North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
  • North America dominated the global animal drug compounding market in 2019. This is ascribed to well-established market, large number of pharmacists and focus on addressing drug shortages. Moreover, ideal regulation by the FDA is likely to augment the animal drug compounding market in North America. Favorable regulatory policies and rise in demand for customized compounded medication to meet the needs of small animals drive the market in the region.
  • The market in Asia Pacific is projected to grow at a rapid pace during the forecast period. Well-established healthcare infrastructure and rise in acceptance of compounded veterinary preparations are the key factors anticipated to propel the market in the region. Rise in pet ownership is expected to drive the animal drug compounding market in the region.

Animal Drug Compounding Market: Major Players

  • Key players operating in the global animal drug compounding market include
    • Wedgewood Pharmacy
    • Triangle Compounding Pharmacy
    • Davis Islands Pharmacy
    • Custom Med Compounding Pharmacy
    • Central Compounding Center South
    • Wellness Pharmacy of Cary
    • Caringbah Compounding Pharmacy
    • Millers Pharmacy
    • Smith's Pharmacy
  • These players focus on adopting various strategies for the expansion of product offerings, development of personalized and emergency compounded drugs, and strategies to strengthen geographic presence. Moreover, companies offer loyalty programs, as new players enter the market with end-to-end solutions.

Animal Drug Compounding Market – Scope of the Report

TMR’s report on the global animal drug compounding market studies the past as well as current growth trends and opportunities to gain valuable insights of these indicators for the market during the forecast period from 2020 to 2030. The report provides the overall revenue of the global animal drug compounding market for the period from 2018 to 2030, considering 2019 as the base year and 2030 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global animal drug compounding market for the forecast period.

The report has been prepared after an extensive research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global animal drug compounding market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts also employed a combination of top-down and bottom-up approaches to study various phenomena in the global animal drug compounding market.

The report comprises an elaborate executive summary, along with a snapshot of the growth behavior of various segments and sub-segments included in the scope of the study. Additionally, the report sheds light on the changing competitive dynamics in the global animal drug compounding market. These indices serve as valuable tools for existing market players as well as for entities interested in participating in the global animal drug compounding market. The next section of the global animal drug compounding market report highlights the USPs, which include technological advancements, regulatory scenario across globe, overview of animal drug compounding (benefits, risks, challenges, etc.), and COVID-19 pandemic impact on global animal drug compounding market.

The report delves into the competition landscape of the global animal drug compounding market. Key players operating in the global animal drug compounding market have been identified, and each one of these has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players profiled in the global animal drug compounding market report.

Key Questions Answered in Animal Drug Compounding Market Report

  • What are the sales/revenue generated by animal drug compounding across all regions during the forecast period?
  • What are the key trends in the global animal drug compounding market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which region is set to expand at the fastest CAGR during the forecast period?
  • Which segment will have the highest revenue globally in 2030 and which segment will grow at the highest CAGR during the forecast period?
  • What was the market share of different companies operating in the global market in 2019?
  • What were the strengths and weaknesses of major players in 2019?
  • What was the competitive analysis of major players in 2019?
  • What was the market share analysis of different companies operating in the global market in 2019?

Animal Drug Compounding Market – Research Objectives and Research Approach

The comprehensive report on the global animal drug compounding market begins with an overview of the market, followed by the scope and objectives of the study. Following this, the report provides detailed explanation of the objectives of the study and healthcare compliances laid down by accredited agencies in the purview of research in the global animal drug compounding market. It is followed by market introduction, market dynamics, and an overview of the global animal drug compounding market, which includes TMR analysis of market drivers, restraints, and trends affecting the growth of the market. Furthermore, Y-o-Y analysis with elaborate insights has been provided to understand the Y-o-Y trends of the global animal drug compounding market.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed in the compilation. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

Revenue generated by key product manufacturers has been mapped to ascertain the size of the global animal drug compounding market in terms of value. The forecast presented here assesses the total revenue generated in the global animal drug compounding market. In order to provide an accurate forecast, we initiated by sizing up the current animal drug compounding market with the help of the parent market.

The report analyzes the global animal drug compounding market in terms of product, animal type, dosage form, route of administration, and region. Key segments under each criteria have been studied at length, and the market share for each of these at the end of 2030 has been provided. These valuable insights would help market stakeholders in making informed business decisions for investments in the global animal drug compounding market.

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

Animal Drug Compounding Market – Segmentation

Product

  • Anti-infectives
    • Metronidazole
    • Ketoconazole
    • Other Antibiotics
  • Anti-inflammatory
    • Prednisolone
    • Tramadol
    • Other Anti inflammatory
  • CNS Agents
    • Potassium bromide
    • Gabapentin
    • Other CNS agents
  • GI Drugs
    • Apomorphine 
    • Ursodiol
    • Cisapride
    • Other GI Drugs
  • Others
    • Methimazole
    • Other drugs
Animal Type
  • Companion Animal
    • Dogs
    • Cats
    • Others
  • Livestock Animal
Dosage Form
  • Capsule
  • Suspension
  • Solution
  • Powders
  • Others
Route of Administration
  • Oral
  • Injectable
  • Topical
  • Rectal
  • Ocular
Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

With a robust experience in creating exceptional market reports, Transparency Market Research has emerged as one of the trusted market research companies among a large number of stakeholders and CXOs. Every report at Transparency Market Research goes through rigorous research activity in every aspect. The researchers at TMR keep a close watch on the market and extract beneficial growth-boosting points. These points help the stakeholders to strategize their business plans accordingly.

TMR researchers conduct exhaustive qualitative and quantitative research. This research involves taking inputs from the experts in the market, focused attention on recent developments, and others. This method of research makes TMR stand out from other market research firms.

Here's how Transparency Market Research helps the stakeholders and CXOs through the reports:

Inculcation and Evaluation of Strategic Collaborations: The TMR researchers analyze recent strategic activities like mergers, acquisitions, partnerships, collaborations, and joint ventures. All the information is compiled and included in the report.

Perfect Market Size Estimations: The report analyzes the demographics, growth potential, and capability of the market through the forecast period. This factor leads to the estimation of the market size and also provides an outline about how the market will retrieve growth during the assessment period.

Investment Research: The report focuses on the ongoing and upcoming investment opportunities across a particular market. These developments make the stakeholders aware of the current investment scenario across the market.

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Global Animal Drug Compounding Market Analysis and Forecast, by Product 

    3.1. Introduction & Definition

    3.2. Key Findings / Developments

    3.3. Global Animal Drug Compounding Market Value (US$ Mn) Forecast, by Product, 2018–2030

        3.3.1. Anti-infectives

            3.3.1.1. Metronidazole

            3.3.1.2. Ketoconazole

            3.3.1.3. Other Antibiotics

        3.3.2. Anti-inflammatory

            3.3.2.1. Prednisolone

            3.3.2.2. Tramadol

            3.3.2.3. Other Anti inflammatory

        3.3.3. CNS Agents

            3.3.3.1. Potassium bromide

            3.3.3.2. Gabapentin

            3.3.3.3. Other CNS agents

        3.3.4. GI Drugs

            3.3.4.1. Apomorphine 

            3.3.4.2. Ursodiol

            3.3.4.3. Cisapride

            3.3.4.4. Other GI Drugs

        3.3.5. Others

            3.3.5.1. Methimazole

            3.3.5.2. Other drugs

    3.4. Market Attractiveness Analysis, by Product

4. Global Animal Drug Compounding Market Analysis and Forecast, by Animal Type

    4.1. Introduction & Definition

    4.2. Key Findings / Developments

    4.3. Global Animal Drug Compounding Market Value (US$ Mn) Forecast, by  Animal  Type, 2018–2030

        4.3.1. Companion Animal

            4.3.1.1. Dogs

            4.3.1.2. Cats

            4.3.1.3. Others

        4.3.2. Livestock

    4.4. Global Animal Drug Compounding Market Attractiveness Analysis, by Animal Type

5. Global Animal Drug Compounding Market Analysis and Forecast, by Dosage Form

    5.1. Introduction & Definition

    5.2. Key Findings / Developments

    5.3. Global Animal Drug Compounding Market Value (US$ Mn) Forecast, by Dosage Form, 2018–2030

        5.3.1. Capsule

        5.3.2. Solution 

        5.3.3. Powders

        5.3.4. Suspension

        5.3.5. Others

    5.4. Global Animal Drug Compounding Market Attractiveness Analysis, by Dosage Form

6. Global Animal Drug Compounding Market Analysis and Forecast, by Route of Administration

    6.1. Introduction & Definition

    6.2. Key Findings / Developments

    6.3. Global Animal Drug Compounding Market Value (US$ Mn) Forecast, by Route of Administration, 2018–2030

        6.3.1. Oral

        6.3.2. Injectable

        6.3.3. Topical

        6.3.4. Rectal

        6.3.5. Ocular

    6.4. Global Animal Drug Compounding Market Attractiveness Analysis, by Route of Administration

7. Global Animal Drug Compounding Market Analysis and Forecast, by Region 

    7.1. Key Findings

    7.2. Global Animal Drug Compounding Market Value (US$ Mn) Forecast, by Region

        7.2.1. North America

        7.2.2. Europe 

        7.2.3. Asia Pacific

        7.2.4. Latin America 

        7.2.5. Middle East & Africa

    7.3. Global Animal Drug Compounding Market Attractiveness Analysis, by Region

8. North America Animal Drug Compounding Market Analysis and Forecast

    8.1. Introduction

        8.1.1.  Key Findings

    8.2. North America Animal Drug Compounding Market Value (US$ Mn) Forecast, by Product, 2018–2030

        8.2.1. Anti-infectives

            8.2.1.1. Metronidazole

            8.2.1.2. Ketoconazole

            8.2.1.3. Other Antibiotics

        8.2.2. Anti-inflammatory

            8.2.2.1. Prednisolone

            8.2.2.2. Tramadol

            8.2.2.3. Other Anti inflammatory

        8.2.3. CNS Agents

            8.2.3.1. Potassium Bromide

            8.2.3.2. Gabapentin

            8.2.3.3. Other CNS agents

        8.2.4. GI Drugs

            8.2.4.1. Apomorphine 

            8.2.4.2. Ursodiol

            8.2.4.3. Cisapride

            8.2.4.4. Other GI Drugs

        8.2.5. Others

            8.2.5.1. Methimazole

            8.2.5.2. Other drugs

    8.3. North America Animal Drug Compounding Market Value (US$ Mn) Forecast, by Animal Type, 2018–2030

        8.3.1. Companion Animal

            8.3.1.1. Dogs

            8.3.1.2. Cats

            8.3.1.3. Others

        8.3.2. Livestock Animal

    8.4. North America Animal Drug Compounding Market Value (US$ Mn) Forecast, by Dosage Form, 2018–2030

        8.4.1. Capsule

        8.4.2. Solution 

        8.4.3. Powders

        8.4.4. Suspension

        8.4.5. Others

    8.5. North America Animal Drug Compounding Market Value (US$ Mn) Forecast, by Route of Administration, 2018–2030

        8.5.1. Oral

        8.5.2. Injectable

        8.5.3. Topical

        8.5.4. Rectal

        8.5.5. Ocular

    8.6. North America Animal Drug Compounding Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

        8.6.1. U.S.

        8.6.2. Canada

9. Europe Animal Drug Compounding Market Analysis and Forecast

    9.1. Introduction

        9.1.1.  Key Findings

    9.2. Europe Animal Drug Compounding Market Value (US$ Mn) Forecast, by Product, 2018–2030

        9.2.1. Anti-infectives

            9.2.1.1. Metronidazole

            9.2.1.2. Ketoconazole

            9.2.1.3. Other Antibiotics

        9.2.2. Anti-inflammatory

            9.2.2.1. Prednisolone

            9.2.2.2. Tramadol

            9.2.2.3. Other Anti inflammatory

        9.2.3. CNS Agents

            9.2.3.1. Potassium Bromide

            9.2.3.2. Gabapentin

            9.2.3.3. Other CNS agents

        9.2.4. GI Drugs

            9.2.4.1. Apomorphine 

            9.2.4.2. Ursodiol

            9.2.4.3. Cisapride

            9.2.4.4. Other GI Drugs

        9.2.5. Others

            9.2.5.1. Methimazole

            9.2.5.2. Other drugs

    9.3. Europe Animal Drug Compounding Market Value (US$ Mn) Forecast, by Animal Type, 2018–2030

        9.3.1. Companion Animal

            9.3.1.1. Dogs

            9.3.1.2. Cats

            9.3.1.3. Others

        9.3.2. Livestock Animal

    9.4. Europe Animal Drug Compounding Market Value (US$ Mn) Forecast, by Dosage Form, 2018–2030

        9.4.1. Capsule

        9.4.2. Solution 

        9.4.3. Powders

        9.4.4. Suspension

        9.4.5. Others

    9.5. Europe Animal Drug Compounding Market Value (US$ Mn) Forecast, by Route of Administration, 2018–2030

        9.5.1. Oral

        9.5.2. Injectable

        9.5.3. Topical

        9.5.4. Rectal

        9.5.5. Ocular

    9.6. Europe Animal Drug Compounding Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

        9.6.1. Germany

        9.6.2. U.K.

        9.6.3. France

        9.6.4. Italy

        9.6.5. Spain

        9.6.6. Rest of Europe

10. Asia Pacific Animal Drug Compounding Market Analysis and Forecast

    10.1. Introduction

        10.1.1.  Key Findings

    10.2. Asia Pacific Animal Drug Compounding Market Value (US$ Mn) Forecast, by Product, 2018–2030

        10.2.1. Anti-infectives

            10.2.1.1. Metronidazole

            10.2.1.2. Ketoconazole

            10.2.1.3. Other Antibiotics

        10.2.2. Anti-inflammatory

            10.2.2.1. Prednisolone

            10.2.2.2. Tramadol

            10.2.2.3. Other Anti inflammatory

        10.2.3. CNS Agents

            10.2.3.1. Potassium Bromide

            10.2.3.2. Gabapentin

            10.2.3.3. Other CNS agents

        10.2.4. GI Drugs

            10.2.4.1. Apomorphine 

            10.2.4.2. Ursodiol

            10.2.4.3. Cisapride

            10.2.4.4. Other GI Drugs

        10.2.5. Others

            10.2.5.1. Methimazole

            10.2.5.2. Other drugs

    10.3. Asia Pacific Animal Drug Compounding Market Value (US$ Mn) Forecast, by Animal Type, 2018–2030

        10.3.1. Companion Animal

            10.3.1.1. Dogs

            10.3.1.2. Cats

            10.3.1.3. Others

        10.3.2. Livestock Animal

    10.4. Asia Pacific Animal Drug Compounding Market Value (US$ Mn) Forecast, by Dosage Form, 2018–2030

        10.4.1. Capsule

        10.4.2. Solution 

        10.4.3. Powders

        10.4.4. Suspension

        10.4.5. Others

    10.5. Asia Pacific Animal Drug Compounding Market Value (US$ Mn) Forecast, by Route of Administration, 2018–2030

        10.5.1. Oral

        10.5.2. Injectable

        10.5.3. Topical

        10.5.4. Rectal

        10.5.5. Ocular

    10.6. Asia Pacific Animal Drug Compounding Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

        10.6.1. China

        10.6.2. Japan

        10.6.3. India 

        10.6.4. Australia & New Zealand 

        10.6.5. Rest of Asia Pacific

11. Latin America Animal Drug Compounding Market Analysis and Forecast

    11.1. Introduction

        11.1.1.  Key Findings

    11.2. Introduction

        11.2.1.  Key Findings

    11.3. Latin America Animal Drug Compounding Market Value (US$ Mn) Forecast, by Product, 2018–2030

        11.3.1. Anti-infectives

            11.3.1.1. Metronidazole

            11.3.1.2. Ketoconazole

            11.3.1.3. Other Antibiotics

        11.3.2. Anti-inflammatory

            11.3.2.1. Prednisolone

            11.3.2.2. Tramadol

            11.3.2.3. Other Anti inflammatory

        11.3.3. CNS Agents

            11.3.3.1. Potassium Bromide

            11.3.3.2. Gabapentin

            11.3.3.3. Other CNS agents

        11.3.4. GI Drugs

            11.3.4.1. Apomorphine 

            11.3.4.2. Ursodiol

            11.3.4.3. Cisapride

            11.3.4.4. Other GI Drugs

        11.3.5. Others

            11.3.5.1. Methimazole

            11.3.5.2. Other drugs

    11.4. Latin America Animal Drug Compounding Market Value (US$ Mn) Forecast, by Animal Type, 2018–2030

        11.4.1. Companion Animal

            11.4.1.1. Dogs

            11.4.1.2. Cats

            11.4.1.3. Others

        11.4.2. Livestock Animal

    11.5. Latin America Animal Drug Compounding Market Value (US$ Mn) Forecast, by Dosage Form, 2018–2030

        11.5.1. Capsule

        11.5.2. Solution 

        11.5.3. Powders

        11.5.4. Suspension

        11.5.5. Others

    11.6. Latin America Animal Drug Compounding Market Value (US$ Mn) Forecast, by Route of Administration, 2018–2030

        11.6.1. Oral

        11.6.2. Injectable

        11.6.3. Topical

        11.6.4. Rectal

        11.6.5. Ocular

    11.7. Latin America Animal Drug Compounding Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

        11.7.1. Brazil

        11.7.2. Mexico

        11.7.3. Rest of Latin America

12. Middle East & Africa Animal Drug Compounding Market Analysis and Forecast

    12.1. Introduction

        12.1.1.  Key Findings

    12.2. Introduction

        12.2.1.  Key Findings

    12.3. Introduction

        12.3.1.  Key Findings

    12.4. Latin America Animal Drug Compounding Market Value (US$ Mn) Forecast, by Product, 2018–2030

        12.4.1. Anti-infectives

            12.4.1.1. Metronidazole

            12.4.1.2. Ketoconazole

            12.4.1.3. Other Antibiotics

        12.4.2. Anti-inflammatory

            12.4.2.1. Prednisolone

            12.4.2.2. Tramadol

            12.4.2.3. Other Anti inflammatory

        12.4.3. CNS Agents

            12.4.3.1. Potassium Bromide

            12.4.3.2. Gabapentin

            12.4.3.3. Other CNS agents

        12.4.4. GI Drugs

            12.4.4.1. Apomorphine 

            12.4.4.2. Ursodiol

            12.4.4.3. Cisapride

            12.4.4.4. Other GI Drugs

        12.4.5. Others

            12.4.5.1. Methimazole

            12.4.5.2. Other drugs

    12.5. Latin America Animal Drug Compounding Market Value (US$ Mn) Forecast, by Animal Type, 2018–2030

        12.5.1. Companion Animal

            12.5.1.1. Dogs

            12.5.1.2. Cats

            12.5.1.3. Others

        12.5.2. Livestock Animal

    12.6. Latin America Animal Drug Compounding Market Value (US$ Mn) Forecast, by Dosage Form, 2018–2030

        12.6.1. Capsule

        12.6.2. Solution 

        12.6.3. Powders

        12.6.4. Suspension

        12.6.5. Others

    12.7. Latin America Animal Drug Compounding Market Value (US$ Mn) Forecast, by Route of Administration, 2018–2030

        12.7.1. Oral

        12.7.2. Injectable

        12.7.3. Topical

        12.7.4. Rectal

        12.7.5. Ocular

    12.8. Middle East & Africa Animal Drug Compounding Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

        12.8.1. GCC Countries 

        12.8.2. South Africa 

        12.8.3. Rest of Middle East & Africa 

13. Competitive Landscape

    13.1. Market Player - Competition Matrix (by tier and size of companies)

    13.2.  Company Profiles

        13.2.1.  Wedgewood Pharmacy 

            13.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)

            13.2.1.2. Product Portfolio

            13.2.1.3. Strategic Overview

            13.2.1.4. SWOT Analysis

        13.2.2. Triangle Compounding Pharmacy

            13.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)

            13.2.2.2. Product Portfolio

            13.2.2.3. Strategic Overview

            13.2.2.4. SWOT Analysis

        13.2.3. Davis Islands Pharmacy 

            13.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)

            13.2.3.2. Product Portfolio

            13.2.3.3. Strategic Overview

            13.2.3.4. SWOT Analysis

        13.2.4. Custom Med Compounding Pharmacy

            13.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)

            13.2.4.2. Product Portfolio

            13.2.4.3. Strategic Overview

            13.2.4.4. SWOT Analysis

        13.2.5. Central Compounding Center South

            13.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)

            13.2.5.2. Product Portfolio

            13.2.5.3. Strategic Overview

            13.2.5.4. SWOT Analysis

        13.2.6. Wellness Pharmacy of Cary

            13.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)

            13.2.6.2. Product Portfolio

            13.2.6.3. Strategic Overview

            13.2.6.4. SWOT Analysis

        13.2.7. Caringbah Compounding Pharmacy 

            13.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)

            13.2.7.2. Product Portfolio

            13.2.7.3. Strategic Overview

            13.2.7.4. SWOT Analysis

        13.2.8. Millers Pharmacy

            13.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)

            13.2.8.2. Product Portfolio

            13.2.8.3. Strategic Overview

            13.2.8.4. SWOT Analysis

        13.2.9. Smith's Pharmacy 

            13.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)

            13.2.9.2. Product Portfolio

            13.2.9.3. Strategic Overview

            13.2.9.4. SWOT Analysis

        13.2.10. Specialist Compounding Pharmacy Pte Ltd.

            13.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)

            13.2.10.2. Product Portfolio

            13.2.10.3. Strategic Overview

            13.2.10.4. SWOT Analysis

        13.2.11. Tache Pharmacy 

            13.2.11.1. Company Overview (HQ, Business Segments, Employee Strength)

            13.2.11.2. Product Portfolio

            13.2.11.3. Strategic Overview

            13.2.11.4. SWOT Analysis

List of Tables

Table 01: Global & Asia Pacific Platelet Rich Plasma Market Value (US$ Mn) Forecast, by Animal Type, 2018–2030

Table 02: Global Animal Drug Compounding Market Value (US$ Mn) Forecast, by Product, 2018–2030

Table 03: Global Animal Drug Compounding Market Value (US$ Mn) Forecast, by Anti-infectives, 2018–2030

Table 04: Global Animal Drug Compounding Market Value (US$ Mn) Forecast, by Anti-inflammatory, 2018–2030

Table 05: Global Animal Drug Compounding Market Value (US$ Mn) Forecast, by CNS Agents, 2018–2030

Table 06: Global Animal Drug Compounding Market Value (US$ Mn) Forecast, by GI Drugs, 2018–2030

Table 07: Global Animal Drug Compounding Market Value (US$ Mn) Forecast, by Others, 2018–2030

Table 08: Global Animal Drug Compounding Market Value (US$ Mn) Forecast, by Animal Type, 2018–2030

Table 09: Global Animal Drug Compounding Market Value (US$ Mn) Forecast, by Animal Type, 2018–2030

Table 10: Global Animal Drug Compounding Market Value (US$ Mn) Forecast, by Dosage Form, 2018–2030

Table 11: Global Animal Drug Compounding Market Value (US$ Mn) Forecast, by Route of Administration, 2018–2030

Table 12: Global Animal Drug Compounding Market Value (US$ Mn) Forecast, by Region, 2018–2030

Table 13: North America Animal Drug Compounding Market Value (US$ Mn) Forecast, by Country, 2018–2030

Table 14: North America Animal Drug Compounding Market Value (US$ Mn) Forecast, by Product, 2018–2030

Table 15: North America Animal Drug Compounding Market Value (US$ Mn) Forecast, by Anti-infectives, 2018–2030

Table 16: North America Animal Drug Compounding Market Value (US$ Mn) Forecast, by Anti-inflammatory, 2018–2030

Table 17: North America Animal Drug Compounding Market Value (US$ Mn) Forecast, by CNS Agents, 2018–2030

Table 18: North America Animal Drug Compounding Market Value (US$ Mn) Forecast, by GI Drugs, 2018–2030

Table 19: North America Animal Drug Compounding Market Value (US$ Mn) Forecast, by Others, 2018–2030

Table 20: North America Animal Drug Compounding Market Value (US$ Mn) Forecast, by Animal Type, 2018–2030

Table 21: North America Animal Drug Compounding Market Size (US$ Mn) Forecast, by Companion Animal Type, 2018–2030

Table 22: North America Animal Drug Compounding Market Value (US$ Mn) Forecast, by Dosage form, 2018–2030

Table 23: North America Animal Drug Compounding Market Value (US$ Mn) Forecast, by Route of Administration, 2018–2030

Table 24: Europe Animal Drug Compounding Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 25: Europe Animal Drug Compounding Market Value (US$ Mn) Forecast, by Product, 2018–2030

Table 26: Europe Animal Drug Compounding Market Value (US$ Mn) Forecast, by Anti-infectives, 2018–2030

Table 27: Europe Animal Drug Compounding Market Value (US$ Mn) Forecast, by Anti-inflammatory, 2018–2030

Table 28: Europe Animal Drug Compounding Market Value (US$ Mn) Forecast, by CNS Agents, 2018–2030

Table 29: Europe Animal Drug Compounding Market Value (US$ Mn) Forecast, by GI Drugs, 2018–2030

Table 30: Europe Animal Drug Compounding Market Value (US$ Mn) Forecast, by Others, 2018–2030

Table 31: Europe Animal Drug Compounding Market Value (US$ Mn) Forecast, by Animal Type, 2018–2030

Table 32: Europe Animal Drug Compounding Market Value (US$ Mn) Forecast, by Companion Animal Types, 2018–2030

Table 33: Europe Animal Drug Compounding Market Value (US$ Mn) Forecast, by Dosage Form, 2018–2030

Table 34: Europe Animal Drug Compounding Market Value (US$ Mn) Forecast, by Route of Administration, 2018–2030

Table 35: Asia Pacific Animal Drug Compounding Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 36: Asia Pacific Animal Drug Compounding Market Value (US$ Mn) Forecast, by Product, 2018–2030

Table 37: Asia Pacific Animal Drug Compounding Market Value (US$ Mn) Forecast, by Anti-infectives, 2018–2030

Table 38: Asia Pacific Animal Drug Compounding Market Value (US$ Mn) Forecast, by Anti-inflammatory, 2018–2030

Table 39: Asia Pacific Animal Drug Compounding Market Value (US$ Mn) Forecast, by CNS Agents, 2018–2030

Table 40: Asia Pacific Animal Drug Compounding Market Value (US$ Mn) Forecast, by GI Drugs, 2018–2030

Table 41: Asia Pacific Animal Drug Compounding Market Value (US$ Mn) Forecast, by Others, 2018–2030

Table 42: Asia Pacific Animal Drug Compounding Market Value (US$ Mn) Forecast, by Animal Type, 2018–2030

Table 43: Asia Pacific Animal Drug Compounding Market Value (US$ Mn) Forecast, by Companion Animal Type, 2018–2030

Table 44: Asia Pacific Animal Drug Compounding Market Value (US$ Mn) Forecast, by Dosage Form, 2018–2030

Table 45: Asia Pacific Animal Drug Compounding Market Value (US$ Mn) Forecast, by Route of Administration, 2018–2030

Table 46: Latin America Animal Drug Compounding Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 47: Latin America Animal Drug Compounding Market Value (US$ Mn) Forecast, by Product, 2018–2030

Table 48: Latin America Animal Drug Compounding Market Value (US$ Mn) Forecast, by Anti-infectives, 2018–2030

Table 49: Latin America Animal Drug Compounding Market Value (US$ Mn) Forecast, by Anti-inflammatory, 2018–2030

Table 50: Latin America Animal Drug Compounding Market Value (US$ Mn) Forecast, by CNS Agents, 2018–2030

Table 51: Latin America Animal Drug Compounding Market Value (US$ Mn) Forecast, by GI Drugs, 2018–2030

Table 52: Latin America Animal Drug Compounding Market Value (US$ Mn) Forecast, by Others, 2018–2030

Table 53: Latin America Animal Drug Compounding Market Value (US$ Mn) Forecast, by Animal Type, 2018–2030

Table 54: Latin America Animal Drug Compounding Market Value (US$ Mn) Forecast, by Companion Animal Type, 2018–2030

Table 55: Latin America Animal Drug Compounding Market Value (US$ Mn) Forecast, by Dosage form, 2018–2030

Table 56: Latin America Animal Drug Compounding Market Value (US$ Mn) Forecast, by Route of Administration, 2018–2030

Table 57: Middle East & Africa Animal Drug Compounding Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 58: Middle East & Africa Animal Drug Compounding Market Value (US$ Mn) Forecast, by Product, 2018–2030

Table 59: Middle East & Africa Animal Drug Compounding Market Value (US$ Mn) Forecast, by Anti-infectives, 2018–2030

Table 60: Middle East & Africa Animal Drug Compounding Market Value (US$ Mn) Forecast, by Anti-inflammatory, 2018–2030

Table 61: Middle East & Africa Animal Drug Compounding Market Value (US$ Mn) Forecast, by CNS Agents, 2018–2030

Table 62: Middle East & Africa Animal Drug Compounding Market Value (US$ Mn) Forecast, by GI Drugs, 2018–2030

Table 63: Middle East & Africa Animal Drug Compounding Market Value (US$ Mn) Forecast, by Others, 2018–2030

Table 64: Middle East & Africa Animal Drug Compounding Market Value (US$ Mn) Forecast, by Animal Type, 2018–2030

Table 65: Middle East & Africa Animal Drug Compounding Market Value (US$ Mn) Forecast, by Companion Animal Type, 2018–2030

Table 66: Middle East & Africa Animal Drug Compounding Market Value (US$ Mn) Forecast, by Dosage Form, 2018–2030

Table 67: Middle East & Africa Animal Drug Compounding Market Value (US$ Mn) Forecast, by Route of Administration, 2018–2030

List of Figures

Figure 01: Global Animal Drug Compounding Market Value (US$ Mn) Forecast, 2018–2030

Figure 02: Global Animal Drug Compounding Market Value Share, by Product, 2019

Figure 03: Global Animal Drug Compounding Market Value Share, by Route of Administration, 2019

Figure 04: Global Animal Drug Compounding Market Value Share, by Animal Type, 2019

Figure 05: Global Animal Drug Compounding Market Value Share Analysis, by Product, 2019 and 2030

Figure 06: Global Animal Drug Compounding Market Revenue (US$ Mn), by Anti-infectives, 2018–2030

Figure 07: Global Animal Drug Compounding Market Revenue (US$ Mn), by Anti-inflammatory, 2018–2030

Figure 08: Global Animal Drug Compounding Market Revenue (US$ Mn), by CNS Agents, 2018–2030

Figure 09 Global Animal Drug Compounding Market Revenue (US$ Mn), by GI Drugs, 2018–2030

Figure 10: Global Animal Drug Compounding Market Revenue (US$ Mn), by Others, 2018–2030

Figure 11: Global Animal Drug Compounding Market Attractiveness Analysis, by Product, 2020–2030

Figure 12: Global Animal Drug Compounding Market Value Share Analysis, by Animal Type, 2019 and 2030

Figure 13: Global Animal Drug Compounding Market Revenue (US$ Mn), by Companion Animal, 2018–2030

Figure 14: Global Animal Drug Compounding Market Revenue (US$ Mn), by Live Stock, 2018–2030

Figure 15: Global Animal Drug Compounding Market Attractiveness Analysis, by Animal Type, 2020–2030

Figure 16: Global Animal Drug Compounding Market Value Share Analysis, by Dosage Form, 2019 and 2030

Figure 17: Global Animal Drug Compounding Market Revenue (US$ Mn), by Capsule, 2018–2030

Figure 18: Global Animal Drug Compounding Market Revenue (US$ Mn), by Solution, 2018–2030

Figure 19: Global Animal Drug Compounding Market Revenue (US$ Mn), by Powders, 2018–2030

Figure 20: Global Animal Drug Compounding Market Revenue (US$ Mn), by Suspension, 2018–2030

Figure 21: Global Animal Drug Compounding Market Revenue (US$ Mn), by Others, 2018–2030

Figure 22: Global Animal Drug Compounding Market Attractiveness Analysis, by Dosage Form, 2020–2030

Figure 23: Global Animal Drug Compounding Market Value Share Analysis, by Route of Administration, 2019 and 2030

Figure 24: Global Animal Drug Compounding Market Revenue (US$ Mn), by Oral, 2018–2030

Figure 25: Global Animal Drug Compounding Market Revenue (US$ Mn), by Injectable, 2018–2030

Figure 26: Global Animal Drug Compounding Market Revenue (US$ Mn), by Topical, 2018–2030

Figure 27: Global Animal Drug Compounding Market Revenue (US$ Mn), by Rectal, 2018–2030

Figure 28: Global Animal Drug Compounding Market Revenue (US$ Mn), by Ocular, 2018–2030

Figure 29: Global Animal Drug Compounding Market Attractiveness Analysis, by Route of Administration, 2020–2030

Figure 30: Global Animal Drug Compounding Market Value Share Analysis, by Region, 2019 and 2030

Figure 31: Global Animal Drug Compounding Market Attractiveness Analysis, by Region, 2020–2030

Figure 32: North America Animal Drug Compounding Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030

Figure 33: North America Animal Drug Compounding Market Value Share (%), by Country, 2019 and 2030

Figure 34: North America Animal Drug Compounding Market Attractiveness Analysis, by Country, 2020–2030

Figure 35: North America Animal Drug Compounding Market Value Share (%), by Product, 2019 and 2030

Figure 36: North America Animal Drug Compounding Market Attractiveness Analysis, by Product, 2020–2030

Figure 37: North America Animal Drug Compounding Market Value Share (%), by Animal Type, 2019 and 2030

Figure 38: North America Animal Drug Compounding Market Attractiveness Analysis, by Animal Type, 2020–2030

Figure 39: North America Animal Drug Compounding Market Value Share (%), by Dosage form, 2019 and 2030

Figure 40: North America Animal Drug Compounding Market Attractiveness Analysis, by Dosage form, 2020–2030

Figure 41: North America Animal Drug Compounding Market Value Share (%), by Route of Administration, 2019 and 2030

Figure 42: North America Animal Drug Compounding Market Attractiveness Analysis, by Route of Administration, 2020–2030

Figure 43: Europe Animal Drug Compounding Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030

Figure 44: Europe Animal Drug Compounding Market Value Share (%), by Country/Sub-region, 2019 and 2030

Figure 45: Europe Animal Drug Compounding Market Attractiveness Analysis, by Country, 2020–2030

Figure 46: Europe Animal Drug Compounding Market Value Share (%), by Product, 2019 and 2030

Figure 47: Europe Animal Drug Compounding Market Attractiveness Analysis, by Product, 2020–2030

Figure 48: Europe Animal Drug Compounding Market Value Share (%), by Animal Type, 2019 and 2030

Figure 49: Europe Animal Drug Compounding Market Attractiveness Analysis, by Animal Type, 2020–2030

Figure 50: Europe Animal Drug Compounding Market Value Share (%), by Dosage Form, 2019 and 2030

Figure 51: Europe Animal Drug Compounding Market Attractiveness Analysis, by Dosage Form, 2020–2030

Figure 52: Europe Animal Drug Compounding Market Value Share (%), by Route of Administration, 2019 and 2030

Figure 53: Europe Animal Drug Compounding Market Attractiveness Analysis, by Route of Administration, 2020–2030

Figure 54: Asia Pacific Animal Drug Compounding Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030

Figure 55: Asia Pacific Animal Drug Compounding Market Value Share (%), by Country/Sub-region, 2019 and 2030

Figure 56: Asia Pacific Animal Drug Compounding Market Attractiveness Analysis, by Country/Sub-region, 2020–2030

Figure 57: Asia Pacific Animal Drug Compounding Market Value Share (%), by Product, 2019 and 2030

Figure 58: Asia Pacific Animal Drug Compounding Market Attractiveness Analysis, by Product, 2020–2030

Figure 59: Asia Pacific Animal Drug Compounding Market Value Share (%), by Animal Type, 2019 and 2030

Figure 60: Asia Pacific Animal Drug Compounding Market Attractiveness Analysis, by Animal Type, 2020–2030

Figure 61: Asia Pacific Animal Drug Compounding Market Value Share (%), by Dosage Form, 2019 and 2030

Figure 62: Asia Pacific Animal Drug Compounding Market Attractiveness Analysis, by Dosage Form, 2020–2030

Figure 63: Asia Pacific Animal Drug Compounding Market Value Share (%), by Route of Administration, 2019 and 2030

Figure 64: Asia Pacific Animal Drug Compounding Market Attractiveness Analysis, by Route of Administration, 2020–2030

Figure 65: Latin America Animal Drug Compounding Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030

Figure 66: Latin America Animal Drug Compounding Market Value Share (%), by Country/Sub-region, 2019 and 2030

Figure 67: Latin America Animal Drug Compounding Market Attractiveness Analysis, by Country/Sub-region, 2020–2030

Figure 68: Latin America Animal Drug Compounding Market Value Share (%), by Product, 2019 and 2030

Figure 69: Latin America Animal Drug Compounding Market Attractiveness Analysis, by Product, 2020–2030

Figure 70: Latin America Animal Drug Compounding Market Value Share (%), by Animal Type, 2019 and 2030

Figure 71: Latin America Animal Drug Compounding Market Attractiveness Analysis, by Animal Type, 2020–2030

Figure 72: Latin America Animal Drug Compounding Market Value Share (%), by Dosage form, 2019 and 2030

Figure 73: Latin America Animal Drug Compounding Market Attractiveness Analysis, by Dosage form, 2020–2030

Figure 74: Latin America Animal Drug Compounding Market Value Share (%), by Route of Administration, 2019 and 2030

Figure 75: Latin America Animal Drug Compounding Market Attractiveness Analysis, by Route of Administration, 2020–2030

Figure 76: Middle East & Africa Animal Drug Compounding Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030

Figure 77: Middle East & Africa Animal Drug Compounding Market Value Share (%), by Country/Sub-region, 2019 and 2030

Figure 78: Middle East & Africa Animal Drug Compounding Market Attractiveness Analysis, by Country/Sub-region, 2020–2030

Figure 79: Middle East & Africa Animal Drug Compounding Market Value Share (%), by Product, 2019 and 2030

Figure 80: Middle East & Africa Animal Drug Compounding Market Attractiveness Analysis, by Product, 2020–2030

Figure 81: Middle East & Africa Animal Drug Compounding Market Value Share (%), by Animal Type, 2019 and 2030

Figure 82: Middle East & Africa Animal Drug Compounding Market Attractiveness Analysis, by Animal Type, 2020–2030

Figure 83: Middle East & Africa Animal Drug Compounding Market Value Share (%), by Dosage Form, 2019 and 2030

Figure 84: Middle East & Africa Animal Drug Compounding Market Attractiveness Analysis, by Dosage Form, 2020–2030

Figure 85: Middle East & Africa Animal Drug Compounding Market Value Share (%), by Route of Administration, 2019 and 2030

Figure 86: Middle East & Africa Animal Drug Compounding Market Attractiveness Analysis, by Route of Administration, 2020–2030

Figure 87: Global Animal Drug Compounding Market Strategy, by Top Pharmacies, 2019

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

Request Customization

Animal Drug Compounding Market